Result
-€506,242 -€506,242
From profit to loss in 2025, after a profit of €252,710 in 2024.
Corpowell
Lifetime
6 annual accounts with figures on one time axispeak €304,223 (2024)
-€383,149▼ €687,372
lowest -€506,242 (2025)
-€506,242▼ €758,952
peak €1.8m (2025)
€1.8m▲ 556%
€1.6m▼ 11.9%
peak 0.4 FTE (2025)
0.4 FTE
Board6 names since 2020
4 directors and 3 others
Owners
57%
Documentsfilings and deeds
29-09-202660 days late
2025abbreviated format
Gross margin from €304,223 to -€383,149Loss of €506,2425 directors appointed, 1 resignation 04-09Equity from €268,539 to €1.8mInvestments €162,154Cash from €60,641 to €402,186
Key points
from the 2025 annual accountsInvestments
€167,961 2.1 × depreciation
Green is investment, beige is depreciation.
Liquidity
1.95 was 1.08 in 2024
Short-term debts fell from €1.7m to €1.5m.
Filings
6 annual accounts 3 late
The 2025 accounts came latest: 60 days after the end of the period.
At the same address
224 companies
Position in the sector
-€506,242
Lower net result than 95% of companies in wholesale trade. Sector median €38,114 · 10,723 companies.
Turnover not published (abbreviated or micro format)Equity +556%: capital increase
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,592 companies had the same profile as Corpowell has now. Each dot stands for 9 companies, two years later.
87.4%
were still trading
9.4%
stopped another way
3.0%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,592 companies, not a prediction for Corpowell. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director,
Director, , since 23-07-2025
Director, , since 23-07-2025
Director, since 23-07-2025
Auditor
- 57%score equity €291,054 (2025) · 2025 annual accounts of
Recent changes
Registered office moved from Schilde to Antwerp
New registered office: Frankrijklei 5, 2000 Antwerpen · Previous registered office: Den Aard 18 bus A, 2970 Schilde · Registered office clause: Den Aard 18 bus A, 2970 Schilde · Board meeting of 07-10-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0742572315
5 directors appointed, 1 resignation
1,300 new shares · 2,000 new shares · Appointments: (company auditor), , , and · General meeting of 23-07-2025 · Gazette deed
Capital increase of €150,000
167 new shares · . holds 167 shares · General meeting of 28-03-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Corpowell Antwerp | €3.4m | -€0.4m | 52.2% | 0.4 |
| VERSO FINANCE Ixelles | €1.1m | -€0.02m | -47.3% | 1 |
| FIDELMED Ghent | €3.1m | -€1.3m | 20.7% | 3.3 |
| NUTWAY Mons | €1.9m | -€0.004m | 74.6% | 0 |
| BRUCO MEDICAL Wommelgem | €1.2m | -€0.08m | -30.4% | 1.5 |
| D.L.H. Mechelen | €1.8m | -€0.04m | 18.7% | 4.4 |
| DD DENTAL Antwerp | €8.7m | -€0.06m | 4.1% | - |
These companies have the same main activity as Corpowell: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.1m and €8.7m, founded between 2013 and 2023.
Official details
Source: KBO- Status
- Active since 28-01-2020Normal situation
- Registered office
- 231 active companies are registered at this address38 started in the 12 months before. Source: KBO register, as of 12 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 2 others
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.301.175.8372000 Antwerp, since 01-04-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 07-10-2025
Insights on Corpowell
Corpowell files the abbreviated format. That format states no turnover. The gross margin fell from -€1,545 in 2020 to -€383,149 in 2025.
holds 57% of the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Corpowell
- What is the company number of Corpowell?
- The company number of Corpowell is 0742.572.315. The VAT number is the same number with BE in front: BE 0742.572.315.
- Where is Corpowell based?
- The registered office is at Frankrijklei 5, 2000 Antwerp.Company details
- What does Corpowell do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Corpowell?
- Corpowell is a private limited company (BV).
- When was Corpowell founded?
- Corpowell was founded on 28-01-2020.
- Is Corpowell still active?
- Yes, Corpowell is an active enterprise in the KBO register.
- How many employees does Corpowell have?
- Corpowell had an average of 0.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Corpowell fall under?
- In its 2025 annual accounts, Corpowell states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of Corpowell?
- The annual accounts for financial year 2025 state no turnover. The abbreviated or micro format does not require it.
- Is Corpowell profitable?
- In financial year 2025, Corpowell made a loss of €506,242.
- Where can I find the annual accounts of Corpowell?
- Corpowell filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Corpowell due?
- Corpowell must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.